|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:famotidine
|
|
gptkbp:approves
|
gptkb:1986
|
|
gptkbp:brand
|
gptkb:Pepcid_AC
gptkb:Pepcid_Complete
|
|
gptkbp:category
|
B
compatible
|
|
gptkbp:class
|
H2 antagonist
|
|
gptkbp:code
|
00006-0120
00006-0121
00006-0122
00006-0123
00006-0124
00006-0125
00006-0126
00006-0127
00006-0128
00006-0129
|
|
gptkbp:community_service
|
safe for children over 1 year
|
|
gptkbp:contraindication
|
hypersensitivity to famotidine
|
|
gptkbp:dosage_form
|
gptkb:tablet
suspension
injection
|
|
gptkbp:duration
|
10 to 12 hours
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pepcid
|
|
gptkbp:ingredients
|
gptkb:famotidine
C8 H10 N4 O2 S
|
|
gptkbp:interacts_with
|
gptkb:itraconazole
gptkb:ketoconazole
gptkb:warfarin
antacids
|
|
gptkbp:is_available_on
|
gptkb:drug
prescription medication
|
|
gptkbp:is_used_for
|
treating gastroesophageal reflux disease (GERD)
treating peptic ulcers
treating Zollinger-Ellison syndrome
|
|
gptkbp:lifespan
|
2.5 to 4 hours
|
|
gptkbp:manager
|
oral
intravenous
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:premiered_on
|
1 hour
|
|
gptkbp:rounds
|
urine
|
|
gptkbp:side_effect
|
dizziness
headache
diarrhea
constipation
|
|
gptkbp:storage
|
room temperature
protected from light
|
|
gptkbp:symptoms
|
confusion
hallucinations
hypotension
bradycardia
|
|
gptkbp:uses
|
caution advised
|
|
gptkbp:weight
|
337.43 g/mol
|